You have 9 free searches left this month | for more free features.

Condition

Hodgkin Lymphoma (1)

Hodgkin's Lymphoma (1)

Relapsed or Refractory Hodgkin's Lymphoma (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Unknown status (1)

Sign in for free

Phase

phase 2 (2)

phase 1/phase 2 (1)

Sponsor

Armando Santoro, MD (1)

Fondazione Italiana Linfomi ONLUS (1)

National Research Center for Hematology, Russia (1)

Collaborator

Roche S.p.a (1)

Intervention

atezolizumab (1)

begev (1)

bendamustine (1)

gemcitabine (1)

nivolumab (1)

vinorelbine (1)

Study Documents

Intervention Type

drug (3)

combination product (1)

Funder Type

Other (3)

Study Type

Interventional (3)

BeGEV

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Hodgkin Lymphoma Trial in Moscow (Nivolumab)

Recruiting

Hodgkin Lymphoma

Nivolumab

Moscow, Russian Federation

National Research Center for Hematology

Dec 13, 2022

Relapsed or Refractory Hodgkin's Lymphoma Trial in Italy (Atezolizumab, BEGEV)

Not yet recruiting

Relapsed or Refractory Hodgkin's Lymphoma

Atezolizumab
BEGEV

Candiolo, Turin, Italy
+18 more

Mar 17, 2022

Hodgkin's Lymphoma Trial in Rozzano (Bendamustine, Gemcitabine, Vinorelbine)

Unknown status

Hodgkin's Lymphoma

Bendamustine
+2 more

Rozzano, MI, Italy

Istituto Clinico Humanitas

Jan 28, 2014